| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/05/2008 | US7326835 Inbred corn line PHADA |
| 02/05/2008 | US7326834 Inbred corn line G06-NP2744 |
| 02/05/2008 | US7326833 Inbred maize line PH705 |
| 02/05/2008 | US7326831 Soybean cultivar S06-MT9211059 |
| 02/05/2008 | US7326830 Soybean variety XB26V05 |
| 02/05/2008 | US7326827 Sodium/proton antiporter gene |
| 02/05/2008 | US7326826 Selection of fungal resistant grape somatic embryos |
| 02/05/2008 | US7326825 Methods of ungulate nuclear transfer |
| 02/05/2008 | US7326824 Regeneration of animal embryo; for use as therapeutic or diagnostic tool in gene therapy; for use in generation of transgenic animals |
| 02/05/2008 | US7326773 PRO6493 antibodies |
| 02/05/2008 | US7326767 Immunotherapeutic methods using epitopes of WT-1 and GATA-1 |
| 02/05/2008 | US7326692 Induction of immunity using inhibitors of granzymes |
| 02/05/2008 | US7326684 Peptides for enhancing resistance to microbial infections |
| 02/05/2008 | US7326681 Methods for producing modified glycoproteins |
| 02/05/2008 | US7326678 Obesity-related disease or disorder, hyperlipidemias, atherosclerosis, diabetes, and hypertension |
| 02/05/2008 | US7326572 Culturing in a medium including Activin A to cause differentiation into endoderm cells that express the markers Sox 17, HNF313 and HNF4a; pancreatic islet cells |
| 02/05/2008 | US7326571 Decellularized bone marrow extracellular matrix |
| 02/05/2008 | US7326570 Induction of tubular morphogenesis using pleiotrophin |
| 02/05/2008 | US7326569 Hybridoma cell lines producing chimeric antibody having the variable regions of the antibody produced by a cell line with ATCC (TM) deposit number HB11364, HB11637, or HB11363 |
| 02/05/2008 | US7326568 Recombinant expression of heterologous nucleic acids in protozoa |
| 02/05/2008 | US7326551 Nucleotide sequences coding polypeptide for use in generation of bacteria which generate synthetic fuels |
| 02/05/2008 | US7326549 Myo-inositol oxygenases |
| 02/05/2008 | US7326545 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 02/05/2008 | US7326537 In human blood, urine, saliva, tissue biopsy or autopsy material; immunoassay using a mono- or polyclonal antibody; detecting overexpression; diagnosis |
| 02/05/2008 | US7326530 Method for localizing polypeptide on cell surface |
| 02/05/2008 | US7326419 Membrane proteins or polypeptides, used as vaccines or for medical diagnosis |
| 02/05/2008 | US7326417 IGF-1 as feline vaccine adjuvant, in particular against feline retroviruses |
| 02/05/2008 | US7326413 Antibodies against the PRO1434 polypeptide |
| 02/05/2008 | US7326411 Use of amino-terminally truncated RANTES to inhibit HIV viral replication |
| 02/05/2008 | US7326385 Plate and method for high throughput screening |
| 02/05/2008 | CA2348240C Transcriptional activator lec1 nucleic acids, polypeptides and their uses |
| 02/05/2008 | CA2187161C Dna encoding precursor of interleukin-1.beta. converting enzyme-related cysteine proteinase ii (icerel-ii) |
| 02/01/2008 | WO2007012188A1 GLP/1/EXENDM 4 IgG Fc FUSION CONSTRUCTS FOR TREATMENT OF DIABETES |
| 02/01/2008 | CA2658673A1 Composition and method for prevention and treatment of type i and type ii diabetes |
| 01/31/2008 | WO2008014450A2 Model taste cells and methods of use for identifying modulators of taste sensation |
| 01/31/2008 | WO2008014426A2 Methods of inhibiting tumor cell aggressiveness using the microenvironment of human embryonic stem cells |
| 01/31/2008 | WO2008014420A2 Non-human animal models for b-cell non-hodgkin's lymphoma and uses thereof |
| 01/31/2008 | WO2008014240A2 Dimeric iap inhibitors |
| 01/31/2008 | WO2008013953A2 Tyrosine phosphorylation sites |
| 01/31/2008 | WO2008013935A2 Tyrosine phosphorylation sites |
| 01/31/2008 | WO2008013863A2 Generation of adipose tissue and adipocytes |
| 01/31/2008 | WO2008013809A1 Cell culture methods |
| 01/31/2008 | WO2008013737A2 Compositions for reprogramming a cell and uses therefor |
| 01/31/2008 | WO2008013664A2 Methods of producing pancreatic hormones |
| 01/31/2008 | WO2008013557A1 Synthetic cornea from retinal stem cells |
| 01/31/2008 | WO2008013552A2 Fully human hybridoma fusion partner cell lines |
| 01/31/2008 | WO2008013276A1 Therapeutic agent for malignant mesothelioma |
| 01/31/2008 | WO2008013257A1 Monoclonal antibody to soluble lox-1 |
| 01/31/2008 | WO2008013067A1 Human artificial chromosome (hac) vector, and human cell pharmaceutical comprising human artificial chromosome (hac) vector |
| 01/31/2008 | WO2008012675A2 Method for the production of multipotent stem cells, relative kits and uses in the medical field |
| 01/31/2008 | WO2008012503A1 Homologue of pro4426 |
| 01/31/2008 | WO2008012058A1 Identification of a novel type of sucrose synthase and use thereof in fiber modification |
| 01/31/2008 | WO2008011752A2 Drugs for resisting bacteria, viruses, cancers, tumors, irritabilities and defects |
| 01/31/2008 | WO2008011664A1 Method of producing a population of cells |
| 01/31/2008 | WO2007123402A3 Therapeutic intervention in a genetic disease in an individual by modifying expression of an aberrantly or abnormally expressed gene |
| 01/31/2008 | WO2007075807A3 Methods for the directed differentiation of embryonic stem cell |
| 01/31/2008 | WO2007056049A3 Molecular profiling of cancer |
| 01/31/2008 | WO2007016372A3 Method for regenerating an immune system |
| 01/31/2008 | US20080028491 Hybrids of Exacum |
| 01/31/2008 | US20080028489 Guard cell-specific tool for molecular manipulation of drought avoidance/water loss in plants |
| 01/31/2008 | US20080028486 Aluminium Tolerant Barley |
| 01/31/2008 | US20080028485 Inbred corn line UNW1 |
| 01/31/2008 | US20080028484 Inbred corn line MM6 |
| 01/31/2008 | US20080028483 Inbred corn line MN5 |
| 01/31/2008 | US20080028481 Chimeric gene containing several herbicide tolerance genes, plant cell and plant resistant to several herbicides |
| 01/31/2008 | US20080028479 Method for making genetic modifications |
| 01/31/2008 | US20080027413 Blood Products from Mesenchymal Stem Cells |
| 01/31/2008 | US20080027213 Chimeric immunogens |
| 01/31/2008 | US20080027147 polypeptides for use in the diagnosis and treatment of cell proliferative disorders |
| 01/31/2008 | US20080027135 Methods For Identifying Chemical Modulators Of Ras Superfamily Gptase Activity |
| 01/31/2008 | US20080027100 Functionally selective alpha2C adrenoreceptor agonists |
| 01/31/2008 | US20080027025 Protection From And Treatment Of Prion Protein Infection |
| 01/31/2008 | US20080027021 Use of cpg oligodeoxynucleotides to induce angiogenesis |
| 01/31/2008 | US20080027020 Human Neuropeptide Receptor |
| 01/31/2008 | US20080027015 Methods and Materials for Modulating Enac-Beta |
| 01/31/2008 | US20080027004 Phosphorylated COP1 molecules and uses thereof |
| 01/31/2008 | US20080027002 Compositions and methods for targeting cancer-specific transcription complexes |
| 01/31/2008 | US20080027001 Nogo receptor functional motifs, peptide mimetics, and mutated functional motifs related thereto, and methods of using the same |
| 01/31/2008 | US20080026999 Dehydration, cyclization of peptide; prevention, therapy for bacteria infections; amino acid sequences |
| 01/31/2008 | US20080026995 Therapeutic vaccine targeted against p-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers |
| 01/31/2008 | US20080026992 Tyrosine Phosphorylation of Cdk Inhibitor Proteins of the Cip/Kip Family |
| 01/31/2008 | US20080026989 Human Ependymin |
| 01/31/2008 | US20080026985 Control of gene expression |
| 01/31/2008 | US20080026982 Mutant APOBEC3G molecules for inhibiting replication of HIV |
| 01/31/2008 | US20080026976 Highly productive alpha-amylases |
| 01/31/2008 | US20080026948 Protein (poly)peptides libraries |
| 01/31/2008 | US20080026466 Comprises expression vector coding regulatory sequences for efficient expression of heterologous polypeptides which confer herbicide, disease and insect resistance in plants; improved stability or shelf life |
| 01/31/2008 | US20080026465 Cell Culturing Method Using Biomechanical Stimulation Loading And System Therefor |
| 01/31/2008 | US20080026464 Nanotopographic Compositions and Methods for Cellular Organization in Tissue Engineered Structures |
| 01/31/2008 | US20080026463 Matrix and method for isolation of hepatic progenitor cells |
| 01/31/2008 | US20080026462 Meningeal-derived stem cells |
| 01/31/2008 | US20080026461 Tissue-like organization of cells and macroscopic tissue-like constructs, generated by macromass culture of cells and the method of macromass culture |
| 01/31/2008 | US20080026460 Propagating embryonic stem cells in three dimensional microwelled system comprising soluble differentiation factors; recovering monodispersed embroid bodies |
| 01/31/2008 | US20080026459 Differential expression via marker within genome; fluorescence activated cell sorting |
| 01/31/2008 | US20080026458 CHIMERIC AND HUMANIZED ANTIBODIES TO alpha5beta1 INTEGRIN THAT MODULATE ANGIOGENESIS |
| 01/31/2008 | US20080026455 Apparatus for propagation of cartilage and bone tissues; tissue engineering and treatment of bone disorders |
| 01/31/2008 | US20080026446 Combination of a growth factor and a protease enzyme |
| 01/31/2008 | US20080026440 polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) systems having greater flexibility for commercial use; for the production of bioactive molecules of interest |
| 01/31/2008 | US20080026439 Pufa polyketide synthase systems and uses thereof |
| 01/31/2008 | US20080026438 Pufa polyketide synthase systems and uses thereof |